Raymond James Initiates Coverage On VBI Vaccines with Outperform Rating, Announces $3 Price Target

Raymond James initiates coverage on VBI Vaccines (NASDAQ:VBIV) with a Outperform rating and a $3 price target.

Benzinga · 11/14/2019 12:02

Raymond James initiates coverage on VBI Vaccines (NASDAQ:VBIV) with a Outperform rating and a $3 price target.